Investment analysts at StockNews.com assumed coverage on shares of Avinger (NASDAQ:AVGR – Get Free Report) in a report released on Monday. The brokerage set a “hold” rating on the medical device company’s stock.
Avinger Stock Up 1.7 %
NASDAQ AVGR opened at $0.95 on Monday. Avinger has a 52 week low of $0.90 and a 52 week high of $9.62. The business has a 50 day moving average price of $1.24 and a 200-day moving average price of $2.26. The company has a market cap of $1.61 million, a price-to-earnings ratio of -0.05 and a beta of 1.17.
Avinger (NASDAQ:AVGR – Get Free Report) last announced its quarterly earnings results on Thursday, August 8th. The medical device company reported ($2.82) EPS for the quarter, missing analysts’ consensus estimates of ($0.43) by ($2.39). The business had revenue of $1.85 million for the quarter, compared to analyst estimates of $2.55 million. On average, equities research analysts anticipate that Avinger will post -4.69 earnings per share for the current year.
Hedge Funds Weigh In On Avinger
About Avinger
Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.
Recommended Stories
- Five stocks we like better than Avinger
- Financial Services Stocks Investing
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- What Are Dividend Challengers?
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.